• hello@europebiobankweek.eu
  • Vienna, Austria
EBW24 Previews
#EBW24 previews: Chairs for panel session “One health: Epidemiological biobanking”

#EBW24 previews: Chairs for panel session “One health: Epidemiological biobanking”

We are pleased to confirm the chairs for the panel session ‘One health: Epidemiological biobanking – cohorts as a show window for populations’: Fatima Qafoud from Qatar Biobank and Professor Kristian Hveem from the Norwegian University of Science and Technology (NTNU). The session takes place on Thursday 16 May 2024 as part of the EBW24 programme.

Fatima Qafoud

Fatima Qafoud attained her Bachelor’s degree in Biomedical Sciences and also accomplished an MBA at Qatar University. At present, Ms. Fatima is in the process of defending her dissertation in Biomedical Sciences at Qatar University, with a particular emphasis on Precision Medicine, establishing the Middle East’s first Atrial Fibrillation familial cohort study. She possesses a wealth of experience in the medical sector’s laboratory management, having served in various roles, including establishing a flow cytometry laboratory for oncology at the Cancer hospital and developing the National Reference lab for COVID-19 testing in Qatar. She presently serves as the director of Qatar Biobank, where she has been since 2013. In this role, she undertook the establishment and design of the Clinic and Laboratory, successfully achieving ISO certification and CAP accreditation. Under her leadership, the laboratory gained recognition as a pioneer in the biobanking industry in the Middle East and throughout the globe.

Professor Kristian Hveem 

Kristian Hveem is a Professor in Medicine and Clinical Epidemiology at the Faculty of Medicine and Health Sciences, the Norwegian University of Science and Technology (NTNU) and a senior consultant at St. Olav’s University Hospital, Trondheim, Norway. He is PI of HUNT Biobank (The European Biobank of the year 2013) and a National Node Director of “Biobank Norway” (BBMRI.no), funded by the Research Council of Norway, representing Norway on the BBMRI-ERIC management committee. From 2010-2013 he served as the first director of the Danish National Biobank (DNB) and he currently leads the Nordic Biobank Network. His main research interest is in molecular, genetic, and clinical epidemiology.

Leave a Reply

Your email address will not be published. Required fields are marked *